MI Visit the ASPET Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Expanded Tables
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minneman, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minneman, K. P.
Molecular Interventions 1:108-116 (2001)
© 2001 American Society of Pharmacology and Experimental Therapeutics


Review

Splice Variants of GPCRs

Kenneth P. Minneman

Department of Pharmacology Emory University Medical School Atlanta, GA 30322

Correspondence: E-mail kminneman{at}pharm.emory.edu; fax (404) 727-0365


Each of the cultured human cells shown above expresses the dopamine D3 receptor, a G protein–coupled receptor, that has been manipulated so as to fluoresce red. Some of the cells additionally express a truncated variant of the D3 receptor (green) that prevents trafficking of both variants to the plasma membrane and that has been associated with schizophrenia. As discussed in the accompanying article, other GPCRs are subject to less drastic forms of splicing that may play important roles in their localization, trafficking, and signaling.

Gprotein–coupled receptors (GPCRs) are encoded by a vast gene superfamily, reflecting the large number of ligands that must be specifically recognized at any given cell surface. The discovery that the variety of GPCRs is further expanded through the generation of splice variants was therefore somewhat surprising. Studies of the functional consequences of alternative splicing have focused on ligand binding, signaling, constitutive activity, and downregulation. However, GPCRs also appear to interact directly with many other intracellular proteins in addition to G proteins. Intriguingly, the domains involved in these interactions are the predominant sites of variation arising through splicing.




This article has been cited by other articles:


Home page
J EndocrinolHome page
C. Y. Wang, Y. Wang, A. H. Y. Kwok, and F. C Leung
Identification of two novel chicken GHRH receptor splice variants: implications for the roles of aspartate 56 in the receptor activation and direct ligand receptor interaction
J. Endocrinol., December 1, 2007; 195(3): 525 - 536.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. Hatae, N. Aksentijevich, H. W. Zemkova, K. Kretschmannova, M. Tomic, and S. S. Stojilkovic
Cloning and Functional Identification of Novel Endothelin Receptor Type A Isoforms in Pituitary
Mol. Endocrinol., May 1, 2007; 21(5): 1192 - 1204.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. Grosse, P. Tarnow, H. Rompler, B. Schneider, R. Sedlmeier, U. Huffstadt, D. Korthaus, M. Nehls, S. Wattler, T. Schoneberg, et al.
N-ethyl-N-nitrosourea-based generation of mouse models for mutant G protein-coupled receptors
Physiol Genomics, September 14, 2006; 26(3): 209 - 217.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Wang, B. Yan, J.-t. Guo, C. Hicks, and Y. Xu
Structural genomics analysis of alternative splicing and application to isoform structure modeling
PNAS, December 27, 2005; 102(52): 18920 - 18925.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Perron, P. Sarret, L. Gendron, T. Stroh, and A. Beaudet
Identification and Functional Characterization of a 5-Transmembrane Domain Variant Isoform of the NTS2 Neurotensin Receptor in Rat Central Nervous System
J. Biol. Chem., March 18, 2005; 280(11): 10219 - 10227.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.